Tag: NXTD

Blue Horseshoe Stocks: RSH Update & More

Radio Shack Corp. RSH

RSH has made regular appearances in our reports over the past couple of months, starting in the beginning of August, when we caught the stock off of its 52-week low of .55.

Following a major run-up to the 1.60-range on August 29th, the stock has been under a general consolidation amid bankruptcy rumors. This week, the company was hinting at possible refinancing deal that would allow them to avoid that situation for the time being, and this morning, that deal was confirmed.

As a result, the stock is up significantly today, having traded as high 1.65 in the premarket. We’re going to want to see support hold at previous resistance points at 1.15 and 1.30. Already, at today’s early highs, we’re seeing more than a 100% increase off of the lows we observed following our most recent RSH alert (.80)

Rockwell Medical, Inc. RMTI

RMTI is another morning gapper that we’re going to place on watch today. With the stock coming off of a recent bottom, it’s going to be interesting to see how today’s development affects its price action.

The company put out a hefty PR this morning regarding a commercialization/distribution deal with Baxter Healthcare (BAX):

WIXOM, Mich., Oct. 3, 2014 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that it has signed an exclusive agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (BAX), to commercialize Rockwell’s hemodialysis concentrate product line in the U.S. and in select overseas markets.>> VIEW PR

BioCryst Pharmaceuticals, Inc. BCRX

BCRX appeared on Wednesday in our extended watchlist, and what has followed has been two fruitful sessions in a row. From a low of 9.89 on Wednesday, we witnessed as the stock bulled its way into yesterday’s close, reaching a daily high of 11.49, a solid 16% overnight increase.

Inovio Pharmaceuticals, Inc. INO

Speaking of pharma plays, INO, a stock that has appeared several times in our reports recently, is also making moves concurrently with the present concern over the Ebola virus outbreak. The company actually has a Ebola vaccine with which they’ve reported success in treating animals with the deadly virus. Anything to do with Ebola is getting a lot of attention at present, and INO is no exception.

Side Note:

Jobs numbers were out this morning, to a positive reception. We will subsequently be looking for dip-and-rip opportunities with regard to options trading. Friday is characteristically a day when premiums start to come down as a result of time decay, with expirations looming. We’re looking at potential opportunities trading Calls in plays like SPY, AA, ISRG, & GPRO.

Extended Watchlist:
HALO, JBLU, WAVX, IAG, SFUN, NXTD

Blue Horseshoe Stocks: MKHD Recap & More

Mount Knowledge Holdings, Inc. MKHD

MKHD was a stock that we had to tag yesterday after noticing the company’s big announcement on our premarket news scanner that it would be acquiring 100% of cyber-security firm Civenergy, Inc., which did $35M in revenues in 2013.

We were anxious to see how the news would affect this low-float stock, and on 9x the average volume, it traded in a range from .042-.085, an intraday spike equaling 102%

We’re going to leave this play on our watchlist, at least until we receive further updates on the acquisition.

MKHD is also receiving a rare “100% Buy” Rating at BARCHART.COM

Terra Tech Corp. TRTC

Also among our interests from yesterday, and indeed the past couple of sessions, was TRTC. We re-flagged this play on Friday at a low of .25, and have witnessed a solid two-day uptrend since then. After seeing a low of .3060 yesterday, the stock would run into the close, ending the day at its high of .37.

That marked a 21% intraday gain, and an increase of 48% over our observed low on Friday.

dELiA*s, Inc. DLIA

DLIA is appearing this morning as a possible bottom-play. The stock is gapping up this morning, and there seems to be a gap to fill on the chart roughly to the 50DMA of .46. Per a PR out this morning, DLIA is “considering a possible sale, merger or ‘other form of business combination‘”, so this is another one that we want to continue to follow as a potential story plays out.

Extended Watchlist:
CNET, CPRX, WYY, SPEX, NXTD

Blue Horseshoe Stocks: CNET Recap & More

ChinaNet Online Holdings, Inc. CNET

CNET made an excellent move following its inclusion in yesterday’s morning report, as the stock would go on to trade in an impressive range from  a low of 2.41 up to a new annual high of 3.98 on nearly 34x its one-month average volume. The strong 65% intraday run came in the first hour of trading, so folks had the chance at some very rapid, very substantial gains. Congrats if you were among them!

Direxion Daily Jr Gld Mnrs Bear 3X ETF (JDST)

We introduced JDST as a way to leverage against the falling prices of gold yesterday, and it’s working out in our favor so far. This ETF didn’t waste any time Monday morning, as it began a morning ascent that would last all day and carry it from a low of 14.65 to 16.88, a modest yet solid gain of 15%

We’ll have our eyes on this one for as long as it appears that the dollar will continue to strengthen.

OTHER ITEMS OF INTEREST

Our scanner yielded three interesting plays with news out of varying subjects.

NXT-ID, Inc. NXTD, has a mobile wallet product that they bill as the truly the first universal secure payment solution, which, as it does not require a smart-phone, provides certain advantages over other eWallet-type products now being pushed by Apple (ApplePay) among others. The stock made a significant move in yesterday’s trading, and will be on our radars today. >>> Shareholder Update PR

China Jo-Jo Drugstores, Inc. CJJDreleased financials yesterday and received a warm reception from traders. Some of the highlights included:

  • Online sales contributed $2.6 million in revenue, an increase of 103.5% from the comparable quarter of prior year
  • Retail sales, which includes online sales, accounted for approximately 80.0% of total revenue, and increased by $2.3 million, or 20.7% year over year to $13.2 million
  • Wholesale, which accounted for approximately 20.0% of total revenue, decreased to $3.3 million from $4.4 million for the same quarter of last year. >>> VIEW FULL PR

Synthetic Biologics, Inc. SYN Earlier last wee the FDA granted orphan drug status to SYN’s monoclonal antibody (mAb) combination, “SYN-005”. After a period of consolidation off of the initial run that produced, the stock is gapping up in the premarket today, so we’ll definitely want to keep an eye peeled.

Extended Watchlist:
OTIV, NETE, NVAX, USAT